1. Z. Hao, D.A. Cooney, N. R. Hartman, C. F. Perno, A. Fridland, A. L. De Vico, M. G. Sarngadharan, S. Broder, D. G. Johns. Factors Determining the Activity of 2′,3′-Dideoxynucleosides in Suppressing Human Immunodeficiency Virus In Vitro, Mol. Pharmacol. 34:431(1988).
2. Z. Hao, D. A. Cooney, D. Farquhar, C. F. Perno, K. Zhang, P. Masood, Y. Wilson, N. R. Hartman, J. Balzarini, D.G. Johns. Potent DNA Chain Termination Activity and Selective Inhibition of Human Immunodeficiency Virus Reverse Transcriptase by 2′,3′-Dideoxyuridine-5′-triphosphate, Mol. Pharmacol. 37:157(1990).
3. P. Van Roey, E.W. Taylor, C.K. Chu, R.F. Schinazi. Correlation of Molecular Conformation and Activity of Reverse Transcriptase Inhibitors, Ann. N. Y. Acad. Sci. 616:29 (1990).
4. P.A. Furman, J.A. Fyfe, M. H. St. Clair, K. Weinhold, J.L. Rideout, A.G. Freeman, S. Nusinoff-Lehrman, D.P. Bolognesi, S. Broder, H. Mitsuya, D.W. Barry. Phosphorylation of 3′-Azido-3′-deoxythymidine and Selective Interaction of the 5′-Triphosphate with Human Immunodeficiency Virus Reverse Transcriptase, Proc. Natl Acad. Sci. U.S.A. 83:8333(1986).
5. M.C. Starnes, Y.-C. Cheng. Cellular Metabolism of 2′,3′-Dideoxycytidine, a Compound Active Against Human Immunodeficiency Virus In Vitro, J. Biol Chem. 262:988(1987).